Antituberculosis therapy for 2012 and beyond

Author： Lauzardo Michael Peloquin Charles A.

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.4, 2012-03, pp. : 511-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapy

By Di Perri Giovanni Aguilar Marucco Diego Mondo Alessandra Gonzalez de Requena Daniel Audagnotto Sabrina Gobbi Federico Bonora Stefano

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 821-836

Informa Healthcare

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 105-105

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 53-53

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tuberculosis

Current Bioactive Compounds, Vol. 1, Iss. 3, 2005-12 ,pp. : 287-289

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy for Liver Cancer: Updated Review in 2012

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-11 ,pp. : 1062-1072

Bentham Science Publishers

Access to resources Recommend Favorite